Trial intelligence / Profile preview

Safety of Inhaled Zanamivir vs Oral Oseltamivir for Influenza Prophylaxis

NCT00980109Phase 4Completed

Sponsor
University of Oxford
Start
Sep 2009
Primary completion
Sep 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of zanamivir, oseltamivir in influenza, sponsored by University of Oxford. Started Sep 2009; status: completed.

02

Drugs

zanamiviroseltamivir
03

Conditions

influenza

Beyond the preview

Go deeper on NCT00980109.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00980109.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call